Literature DB >> 32188211

Prescriptions from Traditional Chinese Medicine compared with salbutamol and montelukast for the treatment of pediatric asthma: a randomized controlled trial.

Hui Du1, Yonghong Wang1, Jian Yu1, Yumin Shi1, Suhuan Li1, Wen Sun1, Yiqun Zhang1, Hong Hu1.   

Abstract

OBJECTIVE: To compare the effects of a series of Traditional Chinese Medicine (TCM) empirical prescriptions with salbutamol and montelukast (SM) in children with asthma.
METHODS: A total of 182 children with asthma were randomized into the TCM group (n = 97) or SM group (n = 85). Patients in the TCM group were treated with a series of TCM prescriptions, whereas those in the SM group received salbutamol and montelukast; both groups received their respective treatment for 12 weeks. Asthma control, changes in scores of TCM symptom patterns, and asthma symptom control (SC) scores after treatment were compared between the two groups.
RESULTS: A higher percentage of patients in the TCM group had asthma control compared with those in the SM group (91.67% and 76.83%, respectively, P = 0.006). Scores for abnormal feces (P < 0.001), hyperhidrosis (P < 0.001), and tongue appearance (P = 0.001) in the TCM group were significantly better than those in the SM group. However, the total scores of TCM symptom patterns and SC scores did not differ significantly between the two groups (P > 0.05).
CONCLUSION: Compared with salbutamol and montelukast, the TCM prescriptions tested were better for symptom control in children with asthma.

Entities:  

Keywords:  Abnormal tongue presentations; Albuterol; Asthma; Chinese medical formula; Feces; Hyperhidrosis; Randomized controlled trial; Syndrome differentiation

Year:  2017        PMID: 32188211

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  2 in total

1.  A comparison of efficacy and safety of complementary and alternative therapies for children with asthma: A protocol for systematic review and meta analysis.

Authors:  Peng Zhou; Leiming Xi; Hongan He; Baoqing Zhang; Yanning Li
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

2.  Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma.

Authors:  Qing Ye; Qiqiang Zhang; Huijuan Yao; Ajing Xu; Yan Liu; Jia Qi; Hai Zhang; Jian Zhang
Journal:  Drug Des Devel Ther       Date:  2021-04-29       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.